![]() |
COVID-19 |
Free Subscription
1 J Infect |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO COVID-19 is free of charge.
Long-term Physical Capacity Following COVID-19: A Prospective, Three-Year Study.
J Infect. 2025 Sep 12:106614. doi: 10.1016/j.jinf.2025.106614.
PubMed
Abstract available
Tracking SARS-CoV-2 Lineages in Pakistan's 2025 COVID-19 Resurgence: Insights
From Genomic Surveillance.
J Med Virol. 2025;97:e70607.
PubMed
Ubiquitination: A Double-Edged Mechanism in Coronavirus Infections.
J Med Virol. 2025;97:e70589.
PubMed
Abstract available
MERS-CoV and SARS-CoV-2 infection in diverse human lung organoid-derived
cultures.
J Virol. 2025 Sep 18:e0109825. doi: 10.1128/jvi.01098.
PubMed
Abstract available
An orally available 4'-fluorouridine prodrug inhibits SFTSV and LCMV infection.
J Virol. 2025 Sep 16:e0117225. doi: 10.1128/jvi.01172.
PubMed
Abstract available
Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute
respiratory syndrome coronavirus 2.
J Virol. 2025 Sep 15:e0082325. doi: 10.1128/jvi.00823.
PubMed
Abstract available
Discovery of a potent covalent inhibitor that unusually distorts the catalytic
dyad of SARS-CoV-2 main protease.
J Virol. 2025 Sep 15:e0065825. doi: 10.1128/jvi.00658.
PubMed
Abstract available
PEDV Nsp14 induces mitophagy-mediated degradation of MAVS to antagonize host
innate immunity and facilitate viral proliferation.
J Virol. 2025;99:e0049825.
PubMed
Abstract available
Florida plan to nix vaccine mandates raises alarm.
Science. 2025;389:1075-1076.
PubMed
Abstract available
Thank you for your interest in scientific medicine.